Ticagrelor cuts post-MI events in diabetes patients

CHICAGO – The benefit from dual-antiplatelet therapy in high-risk patients following a myocardial infarction was especially apparent in post-MI patients with diabetes in a prespecified secondary...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news